Walleye Capital LLC Pep Gen Inc. Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 60,654 shares of PEPG stock, worth $267,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,654

Holding current value

$267,484

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$7.75 - $18.55 $470,068 - $1.13 Million	60,654 New	60,654 $518,000
Q1 2024 May 15, 2024	BUY	$6.63 - $17.3 $428,390 - $1.12 Million	64,614 New	64,614 $949,000

Others Institutions Holding PEPG

# of Institutions

Shares Held

25.2M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

10.7M
Shares

$47.1 Million
1.27% of portfolio
Janus Henderson Group PLC London, X0

2.34M
Shares

$10.3 Million
0.01% of portfolio
Suvretta Capital Management, LLC New York, NY

1.66M
Shares

$7.32 Million
0.56% of portfolio
Viking Global Investors LP

1.48M
Shares

$6.54 Million
0.05% of portfolio
Perceptive Advisors LLC New York, NY

1.41M
Shares

$6.22 Million
0.32% of portfolio

View Full List

About PepGen Inc.

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $104M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

More about PEPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account